검색
Briacell Therapeutics Corp
BCTX관심 목록에 추가
4.010USD
-0.080-1.96%
종가 09-23 16:00（ET）
34.89M시가총액
손실P/E TTM
Briacell Therapeutics Corp 정보 회사
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.
Briacell Therapeutics Corp 프로필
종목 코드 BCTX
회사 이름Briacell Therapeutics Corp
상장일Oct 12, 2006
CEOWilliams (William V)
직원 수22
유형Ordinary Share
회계 연도 종료Oct 12
주소Suite 300 - Bellevue Centre, 235 -15th Street
도시WEST VANCOUVER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Canada
우편 번호V7T 2X1
전화16049211810
웹사이트https://briacell.com/
종목 코드 BCTX
상장일Oct 12, 2006
CEOWilliams (William V)
Briacell Therapeutics Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.90K
+98.69%
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.90K
+98.69%
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.90K
+98.69%
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
56.52K
--
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
56.52K
--
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
56.52K
--
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
28.27K
+99.94%
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
28.27K
+99.94%
Mr. Gadi Levin
Mr. Gadi Levin
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
28.27K
+99.94%
Dr. Miguel A. Lopez-Lago
Dr. Miguel A. Lopez-Lago
Chief Scientific Officer
Chief Scientific Officer
28.26K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.90K
+98.69%
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.90K
+98.69%
Dr. William V. Williams, M.D.
Dr. William V. Williams, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
85.90K
+98.69%
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
56.52K
--
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
56.52K
--
Dr. Giuseppe Del Priore, M.D.
Dr. Giuseppe Del Priore, M.D.
Chief Medical Officer
Chief Medical Officer
56.52K
--
자주 묻는 질문
Briacell Therapeutics Corp의 상위 5대 주주는 누구인가요?
Briacell Therapeutics Corp의 상위 5대 주주는 다음과 같습니다: Dr. William V. Williams, M.D.
Briacell Therapeutics Corp(BCTX)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Briacell Therapeutics Corp의 주식을 보유한 기관은 총 52곳이며, 이들이 보유한 주식의 총 가치는 약 155.47K로 전체 발행 주식의 2.14%를 차지합니다. 이는 2025Q4 대비 -64567.00 증가한 수치입니다.